CorVel Corp (CRVL) director receives 1,500 stock options at $62.45 strike
Rhea-AI Filing Summary
CorVel Corp director Steven J. Hamerslag received a grant of 1,500 Non-Qualified Stock Options on August 6, 2026. The options carry an exercise price of $62.45 per share and are exercisable in four equal annual installments beginning 12 months after the grant date, expiring on August 6, 2036. Following this grant, he holds options for 1,500 underlying shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HAMERSLAG STEVEN J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Qualified Stock Option (right to buy) F1 | 1,500 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 1,500 shares (Direct)
Footnotes (1)
- F1. Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.
Key Figures
Options granted: 1,500 options
Exercise price: $62.45 per share
Underlying shares: 1,500 shares
+2 more
5 metrics
Options granted
1,500 options
Non-Qualified Stock Option grant on August 6, 2026
Exercise price
$62.45 per share
Conversion or exercise price of granted options
Underlying shares
1,500 shares
CorVel common stock underlying the option grant
Expiration date
August 6, 2036
Expiration of the Non-Qualified Stock Option grant
Options after transaction
1,500 options
Total options held directly by reporting person following grant
Key Terms
Non-Qualified Stock Option, exercise price, underlying security, annual installments
4 terms
Non-Qualified Stock Option financial
"1,500 Non-Qualified Stock Options to purchase CorVel common stock"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
exercise price financial
"options carry an exercise price of $62.45 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
"underlying security shares of CorVel common stock"
annual installments financial
"exercisable in four equal annual installments beginning 12 months after grant"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did CorVel (CRVL) director Steven J. Hamerslag report in this Form 4?
Steven J. Hamerslag reported a grant of 1,500 Non-Qualified Stock Options to purchase CorVel common stock at an exercise price of $62.45 per share, expiring on August 6, 2036.
What is the exercise price of the options granted to the CorVel (CRVL) director?
The options granted to the CorVel director have an exercise price of $62.45 per share. This is the price at which he may purchase common shares when the options become exercisable.
When do the newly granted CorVel (CRVL) options to the director vest?
The options vest in four equal annual installments, starting 12 months after the August 6, 2026 grant date. Each year, one-quarter of the 1,500 options becomes exercisable until fully vested.
What is the expiration date of the CorVel (CRVL) options granted to the director?
The granted options expire on August 6, 2036. After this date, any unexercised options will lapse, and the right to purchase CorVel common stock at $62.45 per share will terminate.
Are the CorVel (CRVL) director’s option transactions under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as affirmative. There is no footnote indicating that this specific option grant was made pursuant to a pre-arranged Rule 10b5-1 trading plan.